Development of Novel Drugs from Marine Surface Associated Microorganisms
Open Access
- 28 February 2010
- journal article
- review article
- Published by MDPI AG in Marine Drugs
- Vol. 8 (3), 438-459
- https://doi.org/10.3390/md8030438
Abstract
While the oceans cover more than 70% of the Earth’s surface, marine derived microbial natural products have been largely unexplored. The marine environment is a habitat for many unique microorganisms, which produce biologically active compounds (“bioactives”) to adapt to particular environmental conditions. For example, marine surface associated microorganisms have proven to be a rich source for novel bioactives because of the necessity to evolve allelochemicals capable of protecting the producer from the fierce competition that exists between microorganisms on the surfaces of marine eukaryotes. Chemically driven interactions are also important for the establishment of cross-relationships between microbes and their eukaryotic hosts, in which organisms producing antimicrobial compounds (“antimicrobials”), may protect the host surface against over colonisation in return for a nutrient rich environment. As is the case for bioactive discovery in general, progress in the detection and characterization of marine microbial bioactives has been limited by a number of obstacles, such as unsuitable culture conditions, laborious purification processes, and a lack of de-replication. However many of these limitations are now being overcome due to improved microbial cultivation techniques, microbial (meta-) genomic analysis and novel sensitive analytical tools for structural elucidation. Here we discuss how these technical advances, together with a better understanding of microbial and chemical ecology, will inevitably translate into an increase in the discovery and development of novel drugs from marine microbial sources in the future.Keywords
This publication has 183 references indexed in Scilit:
- Recent Advances in the Chemistry and Biology of Naturally Occurring AntibioticsAngewandte Chemie-International Edition, 2009
- Total Synthesis of Brevetoxin AOrganic Letters, 2008
- Marineosins A and B, Cytotoxic Spiroaminals from a Marine-Derived ActinomyceteOrganic Letters, 2008
- Marine Natural Product Libraries for High-Throughput Screening and Rapid Drug DiscoveryJournal of Natural Products, 2008
- Developing a new resource for drug discovery: marine actinomycete bacteriaNature Chemical Biology, 2006
- Bioactive Microbial MetabolitesThe Journal of Antibiotics, 2005
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus SalinosporaAngewandte Chemie-International Edition, 2003
- Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial ChemistryJournal of Chemical Information and Computer Sciences, 2002
- Antibiotic activity of epiphytic bacteria isolated from intertidal seaweedsMicrobial Ecology, 1985